Literature DB >> 4472557

Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.

A Avramides, R K Baker, S Wallach.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4472557     DOI： 10.1016/0026-0495(74)90070-5

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  6 in total

1.  Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.

Authors:  D G Oreopoulos; H Husdan; J Harrison; H E Meema; K G McNeill; T M Murray; R Ogilvie; A Rapoport
Journal:  Can Med Assoc J       Date:  1977-04-23       Impact factor: 8.262

2.  Bone turnover in Paget's disease: biochemical and kinetic measurements during salmon calcitonin therapy.

Authors:  D J Hosking; W Vennart; L B Huddlestone
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

3.  Long-term measurement of skeletal and lean body mass in Paget's disease of bone treated with synthetic human calcitonin.

Authors:  T J Spinks; G F Joplin; I M Evans; J Pennock; F H Doyle; A S Ranicar
Journal:  Calcif Tissue Int       Date:  1982-09       Impact factor: 4.333

4.  Paget's disease of bone. An update on management.

Authors:  D J Hosking
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

5.  Long-term treatment of Paget's disease of bone with salmon calcitonin.

Authors:  W C Sturtridge; J E Harrison; D R Wilson
Journal:  Can Med Assoc J       Date:  1977-11-05       Impact factor: 8.262

6.  Chronic treatment of Paget's disease of bone with synthetic human calcitonin.

Authors:  R Lang; M Milkman; P S Jensen; A M Vignery
Journal:  Yale J Biol Med       Date:  1981 Sep-Oct
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.